NeuroPace reports preliminary Q4 revenue
Source: SeekingAlpha
2025-01-08 16:14:33 ET
More on Hyperfine, NeuroPace, etc.
- QuidelOrtho: Highly Levered With Questionable Growth
- NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript
- Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
- Jana Partners takes new stake in Lamb Weston, exits BlackLine, among top Q3 trades
- QuidelOrtho surges 14% on Q3 beats; reaffirms 2024 guidance
Read the full article on Seeking Alpha
For further details see:
NeuroPace reports preliminary Q4 revenue
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
1.05% G/L:
$14.45 Last:
7,891 Volume:
$14.30 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
